AbbVie (ABBV) earnings

Earnings (net income) · fiscal 2025
$4.23B

AbbVie (ABBV) reported net income of $4.23B in fiscal 2025 (the year ended December 31, 2025). That is 1.2% lower than the $4.28B of fiscal 2024. Figures as of 18 Nov 2026, 04:27 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$4.23B
Change on fiscal 2024
−1.2%
Growth, 5 years
−1.7% a year
Growth, 10 years
−1.9% a year
Highest on record
$11.84Bfiscal 2022
Lowest on record
$1.77Bfiscal 2014
Fiscal years on record
122014–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

AbbVie earnings, in more detail

Over the five fiscal years to 2025 net income shrank at a compound 1.7% a year; over ten years the rate was −1.9% a year. Across the 12 fiscal years on record (2014–2025), the highest was $11.84B in fiscal 2022 and the lowest $1.77B in fiscal 2014.

History · 12 fiscal years

Earnings (net income) by fiscal year

AbbVie earnings, year by year

AbbVie (ABBV) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$4.23B 1.2% down
2024$4.28B 12.0% down
2023$4.86B 58.9% down
2022$11.84B 2.5% up
2021$11.54B 150.0% up
2020$4.62B 41.4% down
2019$7.88B 38.6% up
2018$5.69B 7.1% up
2017$5.31B 10.8% down
2016$5.95B 15.7% up
2015$5.14B 190.0% up
2014$1.77B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of AbbVie and comparable companies
CompanyEarnings (net income)Fiscal year
Eli Lilly LLY$20.64B2025
Johnson & Johnson JNJ$26.80B2025
AbbVie ABBV$4.23B2025
Merck & Co MRK$18.25B2025
UnitedHealth Group UNH$12.06B2025
Novartis NVS$13.98B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ABBV

AbbVie, figure by figure

AbbVie (ABBV) overview: price, valuation and scorecardAll health care companies by market value

AbbVie earnings: questions and answers

What is AbbVie's net income?

AbbVie (ABBV) reported net income of $4.23B in fiscal 2025 (the year ended December 31, 2025). That is 1.2% lower than the $4.28B of fiscal 2024.

What is the growth rate of AbbVie's net income?

Over the five fiscal years to 2025 net income shrank at a compound 1.7% a year; over ten years the rate was −1.9% a year.

What are the highest and lowest net income figures on record for AbbVie?

Across the 12 fiscal years on record (2014–2025), the highest was $11.84B in fiscal 2022 and the lowest $1.77B in fiscal 2014.

How is AbbVie's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “AbbVie (ABBV) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/ABBV/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.